Tomy Anderson 
Troy Asset Management Ltd’s portfolio moves, tracked quarter by quarter, offer a running look at how this institutional investor rotates capital across its equity holdings. Like all money managers overseeing more than $100 million in US-listed securities, Troy discloses its long positions each quarter via SEC Form 13F. These filings are a snapshot of holdings … Read more
This page tracks Sanofi’s institutional portfolio activity as disclosed in its quarterly Form 13F filings with the SEC. Rather than a one-off news snapshot, think of it as a running ledger — new positions, exits, and size changes get logged here every quarter so you can see how the company’s biotech and pharma stakes shift … Read more
Highbridge Capital Management LLC’s portfolio moves, tracked quarter by quarter based on its SEC Form 13F filings. This profile follows how the fund reshapes its equity holdings over time, using the same disclosures that investors reference when researching portfolio changes, portfolio value shifts, and cash allocation trends at large institutional managers. Each quarter’s filing adds … Read more
This page tracks Boundless Plain Holdings Ltd’s institutional portfolio moves as disclosed in SEC Form 13F filings, updated every quarter as new filings become public. Rather than a one-time snapshot, it’s meant to be a running record of how this fund has repositioned its holdings over time, filing by filing. During the quarter ending 2026-06-30, … Read more
A new Form 4 filing shows Erez Chimovits, a Director and 10%+ Owner of Braveheart Bio, Inc. (BRVE), purchased 1,666,667 shares on the open market on 2026-08-07 at $18.00 per share, a total outlay of $30,000,006.00. Following the purchase, Chimovits holds 11,901,826 shares indirectly, through a trust or entity structure rather than in a personal … Read more
OrbiMed Advisors LLC, a director and 10%-plus owner of Braveheart Bio, Inc. (BRVE), disclosed an open-market purchase of 1,666,667 shares at $18.00 apiece, a cash outlay of $30,000,006.00, according to a Form 4 filed with the SEC. The transaction is dated August 7, 2026, and brings OrbiMed’s indirectly held stake to 11,901,826 shares. The purchase … Read more
TXO Partners, L.P. (TXO) insider Bob R. Simpson disclosed an open-market purchase of 100,000 shares on August 11, 2026, paying $14.27 per share for a total outlay of $1,427,480. Following the trade, Simpson’s directly held stake stands at 9,350,000 shares, according to the Form 4 filed with the SEC. The purchase was made with Simpson’s … Read more
A newly filed Form 4 with the Securities and Exchange Commission shows that Bankers Life & Casualty Co., acting in its capacity as a 10%+ owner, purchased a substantial block of shares in Privacore VPC Asset Backed Credit Fund on August 7, 2026. The filing shows no ticker symbol associated with the fund, consistent with … Read more
QVC Group, Inc. (QVCG) disclosed another insider purchase this week, part of a broader pattern of buying by one of its largest shareholders. According to a Form 4 filed with the SEC, GoldenTree Asset Management LP, listed as a 10%+ owner of the company, purchased 308 shares of QVCG on the open market on August … Read more
Aptiv PLC (APTV) Chair and CEO Kevin P. Clark disclosed an open-market purchase of 51,190 shares on August 10, 2026, according to a Form 4 filing with the SEC. The shares were bought at $48.89 apiece, for a total outlay of $2,502,684.22. Following the transaction, Clark holds 651,016 shares directly, a stake that reflects a … Read more
Rep. Michael Rulli (R-Ohio) has once again disclosed a purchase of Alphabet Inc. Class A shares (GOOGL), according to a Periodic Transaction Report filed under the STOCK Act. The transaction, dated June 25, 2026, was made personally by Rulli and executed through a Merrill Lynch Managed Account. The disclosed value falls between $1,001 and $15,000, … Read more
A newly filed Periodic Transaction Report shows Hon. Michael Rulli, a member of the U.S. House of Representatives, purchased shares of Alphabet Inc. Class A Common Stock (GOOGL) on June 29, 2026. The transaction, disclosed under the STOCK Act, was made by Rulli personally and is valued in the $1,001 to $15,000 range. The holding … Read more